A board established by Oregon State under the psilocybin legalization measure which was approved last year has tabled a report approving use of psilocybin to treat various mental health conditions citing that psilocybin possesses significant health benefits in relation to mental health.
Before arriving at this conclusion, the Oregon Psilocybin Advisory Board subcommittee went through almost 600 studies done on psilocybin from which they established that psychedelic had indeed demonstrated effectiveness in reducing depression and anxiety even in severe conditions.
The board affirmed that all the studies they reviewed used a controlled clinical setting and the report was compiled after two months of intense review. The board noted that psilocybin was found to increase the spiritual welfare across all the studies.
Most of the study participants in the studies rated their experience with psilocybin as meaningful.
The advisory board contains 17 members who were all appointed in March this year by Governor Kate Brown who mandated them to assist in the implementation of the aforementioned psychedelic reform measure.
